These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3938210)

  • 1. Ocular complication of combined intracarotid chemotherapy and osmotic blood-brain barrier disruption.
    Suda K; Nakasu S; Saito A
    Nihon Geka Hokan; 1985 Sep; 54(5):359-63. PubMed ID: 3938210
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACNU delivery to malignant glioma tissue by osmotic blood brain barrier modification with intracarotid infusion of hyperosmoral mannitol].
    Miyagami M; Kagawa Y; Tsubokawa T
    No Shinkei Geka; 1985 Sep; 13(9):955-63. PubMed ID: 2999632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intra-arterial chemotherapy of malignant glioma after osmotic blood-brain barrier disruption].
    Yamada K; Takahama H; Nakai O; Takanashi T; Hosoya T
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2692-6. PubMed ID: 2506817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of brain tumor with phenobarbital and continuous infusion of ACNU into internal carotid artery].
    Yumitori K; Yamashita J; Teraura T; Handa H
    No Shinkei Geka; 1983 Feb; 11(2):165-71. PubMed ID: 6573575
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intra-arterial ACNU chemotherapy of malignant glioma].
    Murayama S; Kawai R; Hirabuki N; Miura T; Mitomo M; Kozuka T; Usio Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Feb; 48(2):144-53. PubMed ID: 3164472
    [No Abstract]   [Full Text] [Related]  

  • 6. Intra-arterial ACNU chemotherapy employing 20% mannitol osmotic blood-brain barrier disruption for malignant brain tumors.
    Miyagami M; Tsubokawa T; Tazoe M; Kagawa Y
    Neurol Med Chir (Tokyo); 1990 Aug; 30(8):582-90. PubMed ID: 1703636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
    Miyagami M; Tazoe M; Kasahara E; Tsubokawa T
    Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas].
    Heimberger K; Samec P; Podreka I; Binder H; Suess E; Reisner T; Deecke L; Steger G; Hiesmayr M; Dittrich C
    Wien Klin Wochenschr; 1987 May; 99(11):385-8. PubMed ID: 3113082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
    Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
    Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of mustoforan in management of malignant glioma].
    Kobiakov GL
    Vopr Onkol; 2007; 53(6):724-9. PubMed ID: 18416147
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intra-arterial ACNU, CDDP chemotherapy for brain metastases from lung cancer: comparison of cases with and without intra-arterial mannitol infusion].
    Iwadate Y; Namba H; Saegusa T; Sueyoshi K
    No Shinkei Geka; 1993 Jun; 21(6):513-8. PubMed ID: 8336809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors.
    Neuwelt EA; Hill SA; Frenkel EP; Diehl JT; Maravilla KR; Vu LH; Clark WK; Rapoport SI; Barnett PA; Lewis SE; Ehle AL; Beyer CW
    Cancer Treat Rep; 1981; 65 Suppl 2():39-43. PubMed ID: 6809316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on postoperative local chemotherapy of malignant brain tumors using ACNU and PSK].
    Saito Y; Hori T; Takami M; Muraoka K; Hokama Y; Numata H
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1963-71. PubMed ID: 6577813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ocular complications of intracarotid chemotherapies with nitrosourea agents].
    Rigal-Sastourne JC; Bidaux F; Mir F; Crepy P; Lucas B; Renard JP; Derosier C; Maurin JF; Bourgeois H
    J Fr Ophtalmol; 1993; 16(5):304-10. PubMed ID: 8331249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracarotid chemotherapy of glioblastoma after induced blood-brain barrier disruption.
    Bonstelle CT; Kori SH; Rekate H
    AJNR Am J Neuroradiol; 1983; 4(3):810-2. PubMed ID: 6410860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretic limitations of intracarotid infusions in brain tumor chemotherapy.
    Fenstermacher JD; Cowles AL
    Cancer Treat Rep; 1977 Jul; 61(4):519-26. PubMed ID: 884689
    [No Abstract]   [Full Text] [Related]  

  • 17. Multimodality treatment of malignant glioma. Effect of chemotherapy with ACNU and immunotherapy with N-CWS.
    Yoshida J; Kobayashi T; Kageyama N
    Neurol Med Chir (Tokyo); 1984 Jan; 24(1):19-26. PubMed ID: 6204234
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary CNS lymphoma treated with combined intra-arterial ACNU and radiotherapy.
    Sonoda Y; Matsumoto K; Kakuto Y; Nishino Y; Kumabe T; Tominaga T; Katakura R
    Acta Neurochir (Wien); 2007 Nov; 149(11):1183-9; discussion 1189. PubMed ID: 17712511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The blood-brain barrier: implications for chemotherapy in brain tumors].
    Boaziz C; Breau JL; Morère JF; Israël L
    Pathol Biol (Paris); 1991 Oct; 39(8):789-95. PubMed ID: 1762838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiotherapy in combination with misonidazole and ACNU in lung neoplasms].
    Asakura H; Maruhashi A; Mashima Y; Kanazawa A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Nov; 43(11):1295-306. PubMed ID: 6584857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.